- CEO
- Mohd Nazlee Kamal
- Full Time Employees
- 62
- Sector
- Producer manufacturing
- Industry
- Miscellaneous manufacturing
- Address
- Kuala Lumpur Malaysia
- IPO Date
- Jun 30, 2005
- Business
- Solution Group Berhad is a Malaysia-based investment holding company that provides engineering education equipment, industrial automation solutions, biopharmaceutical manufacturing and distribution, renewable energy systems, and specialty industrial products. Founded in 1996 and headquartered in Petaling Jaya, Malaysia, the company operates across several primary business segments: Engineering Equipment, Industrial Automation, Biopharmaceuticals, Renewable Energy, and Lubricants. Through its proprietary SOLTEQ brand, the company designs, develops, and manufactures specialized technical training equipment; educational laboratory apparatus; and pilot plant test benches for universities, polytechnics, vocational institutes, and research institutions in disciplines including chemical, mechanical, electrical, thermodynamic, fluid mechanics, and environmental engineering. Its Industrial Automation unit provides supervisory control and data acquisition (SCADA) systems; programmable logic controller (PLC) automation; process control instrumentation; electrical switchboard assembly; and customized industrial mechanical fabrication. Through its healthcare subsidiary Solution Biologics Sdn Bhd, the company engages in the registration, commercialization, formulation, and fill-and-finish manufacturing of biopharmaceuticals and human vaccines, operating a World Health Organization (WHO) Good Manufacturing Practice (GMP) compliant manufacturing facility. Its Renewable Energy unit delivers turnkey engineering, procurement, construction, and commissioning (EPCC) solutions for solar photovoltaic (PV) rooftop systems and energy management projects. Additionally, the company produces and distributes industrial lubricants, metalworking fluids, and specialty industrial chemicals. Solution Group Berhad serves clients across Malaysia, Southeast Asia, South Asia, the Middle East, Africa, and Australia. In recent operational developments, the company has advanced the commercial operationalization of its fill-and-finish biopharmaceutical manufacturing plant; executed strategic supply, marketing, and distribution alliances with CanSino Biologics Inc. for recombinant human vaccines across regional markets; expanded its clean technology division through commercial and industrial rooftop solar PV installations; and implemented corporate restructuring initiatives to accelerate biotechnology and renewable energy business lines alongside its established educational engineering operations.